Epizyme
Founded in 2007, Epizyme, Inc. is a late-stage biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through novel epigenetic medicines. The company is based in Cambridge, MA.
Last updated on
About Epizyme
Founded
2007Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$410MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (69)
